United States · FDA National Drug Code directory
Asclera
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67850-141_f443bbaf-ef8e-4f9e-ba4c-6f87dc58a671
- Product NDC
- 67850-141
- Form
- INJECTION, SOLUTION
- Composition / generic term
- POLIDOCANOL
- Labeler
- Methapharm, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20100601
- Source listing expiry
- 20261231
Source-listed ingredients
- POLIDOCANOL — .01 g/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 mL in 1 AMPULE (67850-141-05) · 67850-141-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →